Xenon Pharmaceuticals Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Xenon Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -24.2 %, a 3.56% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2023 was -25.2 %, a 40.7% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2022 was -17.9 %, a 24.4% increase from 2021.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2021 was -23.7 %, a 50% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -25.2 -7.28 -40.7% Jan 1, 2023 Dec 31, 2023
2022 -17.9 +5.79 +24.4% Jan 1, 2022 Dec 31, 2022
2021 -23.7 -7.9 -50% Jan 1, 2021 Dec 31, 2021
2020 -15.8 +32.9 +67.6% Jan 1, 2020 Dec 31, 2020
2019 -48.7 -1.7 -3.62% Jan 1, 2019 Dec 31, 2019
2018 -47 +18.7 +28.5% Jan 1, 2018 Dec 31, 2018
2017 -65.7 -28 -74.3% Jan 1, 2017 Dec 31, 2017
2016 -37.7 -12.7 -51.1% Jan 1, 2016 Dec 31, 2016
2015 -25 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.